Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SIRT3 agonists(sirtuin 3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H29I2NO3 |
InChIKeyNKCYHTOLLMRNJO-UHFFFAOYSA-N |
CAS Registry782387-91-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | CN | 03 Oct 2021 |